Heron Therapeutics receives Nasdaq minimum bid price deficiency notice
Heron Therapeutics received notice from Nasdaq on June 25, 2026, that the closing bid price of its common shares fell below the $1.00 per share minimum for…
$1.00per share
Company
SEC filing news and material events for HERON THERAPEUTICS, INC. /DE/, briefed from primary-source filings.
1 story
Heron Therapeutics received notice from Nasdaq on June 25, 2026, that the closing bid price of its common shares fell below the $1.00 per share minimum for…